USE OF A PAR-1 ANTAGONIST FOR THE TREATMENT OF A CHRONIC INFLAMMATORY INTESTINAL DISEASE

摘要

The invention relates to the use of a PAR-1 antagonist, in particular selected from vorapaxar, atopaxar and 3-2-(chloro-phenyl)-1-[4-(4-fluoro-benzyl)-piperazine-1-yl]propenone, for the prevention and/or treatment of a chronic inflammatory disease of the intestine and of the colon in a mammal, in particular Crohn's disease.